Company Filing History:
Years Active: 2008
Title: Luis Javier González López: Innovator in Cancer Treatment Peptides
Introduction
Luis Javier González López is an accomplished inventor based in Playa, Cuba, recognized for his significant contributions to the field of Molecular Pharmacology. He holds a patent that is crucial for the development of innovative peptides aimed at treating cancer associated with the human papilloma virus (HPV) and other epithelial tumors. His work exemplifies the potential of peptide-based therapies in oncology.
Latest Patents
Luis has innovated the patent titled "Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors." This invention focuses on identifying peptides capable of obstructing the Casein Kinase II (CKII) phosphorylation domain through direct interaction. The patented technology outlines eleven cyclic peptides with varying amino acid sequences that effectively inhibit CKII phosphorylation in vitro, demonstrating cytotoxicity against HPV-16 transformed cells (CaSki). Additionally, these peptides enhance the sensitivity of the cells to the cytostatic effects of interferon (IFN).
Career Highlights
Luis is affiliated with the Centro de Ingeniería Genética y Biotecnología, a prominent research institution in Cuba that specializes in genetic engineering and biotechnology. His dedication to advancing cancer treatment showcases his commitment to scientific excellence and innovation. The successful development of his patented peptides reflects a significant milestone in targeting epithelial tumors, particularly those linked to oncogenic HPV types.
Collaborations
Throughout his career, Luis has collaborated with esteemed colleagues, including Silvio Ernesto Perea Rodriguez and Osvaldo Reyes Acosta. Together, they have contributed to important research endeavors that seek to improve therapeutic options for cancer patients, demonstrating the value of teamwork in scientific discovery.
Conclusion
Luis Javier González López stands out as a notable inventor in the realm of cancer therapeutics. His groundbreaking work on peptides tailored to disrupt malignancies associated with HPV not only embodies innovation but also offers hope for improved treatment modalities. As the field of Molecular Pharmacology evolves, Luis's contributions will potentially pave the way for more effective interventions against cancer.